Multiple exon skipping strategies to by-pass dystrophin mutations

@article{Pirra2012MultipleES,
  title={Multiple exon skipping strategies to by-pass dystrophin mutations},
  author={L. Pirra},
  journal={Yearbook of Neurology and Neurosurgery},
  year={2012},
  volume={2012},
  pages={115-116}
}
  • L. Pirra
  • Published 2012
  • Medicine
  • Yearbook of Neurology and Neurosurgery

Topics from this paper

Exon 32 Skipping of Dysferlin Rescues Membrane Repair in Patients’ Cells
TLDR
Data obtained confirmed that Dysferlin function is rescued by quasi-dysferlin expression in treated patient cells, supporting the case for a therapeutic antisense-based trial in a subset of dysferlin-deficient patients. Expand
Gene‐based therapies of neuromuscular disorders: an update and the pivotal role of patient organizations in their discovery and implementation
  • S. Braun
  • Medicine
  • The journal of gene medicine
  • 2013
This review updates the state‐of‐the art accomplishments of the multifaceted gene‐based therapies, which include DNA or RNA as either therapeutic tools or targets for the treatment of neuromuscularExpand

References

Multiple exon skipping strategies to by-pass dystrophin mutations
TLDR
This work presents strategies to by-pass intra-exonic dystrophin mutations that clearly demonstrate the importance of tailoring exon skipping strategies to specific patient mutations. Expand